Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion type Assertion NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_head.
- NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion description "[The objective of the study was to describe the antitumoral efficacy and toxicity of temozolomide in patients with aggressive pituitary tumors or carcinomas and evaluate the possible prognostic value of MGMT promoter methylation and protein expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_provenance.
- NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion evidence source_evidence_literature NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_provenance.
- NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion SIO_000772 20660056 NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_provenance.
- NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion wasDerivedFrom befree-20150227 NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_provenance.
- NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_assertion wasGeneratedBy ECO_0000203 NP555377.RAI5axXZCKx8tGdaTHT02RvODct3AdY-STTRqL1YGZDbI130_provenance.